European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Zimbus Breezhaler, indacaterol,glycopyrronium,mometasone furoate, Date of authorisation: 03/07/2020, Revision: 5, Status: Authorised

Submitted by Anonymous (not verified) on 6 September 2024 - 15:26

Human medicines European public assessment report (EPAR): Zimbus Breezhaler, indacaterol,glycopyrronium,mometasone furoate, Date of authorisation: 03/07/2020, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Rystiggo, Rozanolixizumab, Date of authorisation: 05/01/2024, Revision: 3, Status: Authorised

Submitted by Anonymous (not verified) on 6 September 2024 - 14:25

Human medicines European public assessment report (EPAR): Rystiggo, Rozanolixizumab, Date of authorisation: 05/01/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Repatha, evolocumab, Date of authorisation: 17/07/2015, Revision: 26, Status: Authorised

Submitted by Anonymous (not verified) on 6 September 2024 - 14:24

Human medicines European public assessment report (EPAR): Repatha, evolocumab, Date of authorisation: 17/07/2015, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Aspaveli, pegcetacoplan, Date of authorisation: 13/12/2021, Revision: 8, Status: Authorised

Submitted by Anonymous (not verified) on 6 September 2024 - 14:07

Human medicines European public assessment report (EPAR): Aspaveli, pegcetacoplan, Date of authorisation: 13/12/2021, Revision: 8, Status: Authorised

Referral: Lorazepam Macure 4 mg/ml, solution for injection, lorazepam Article 13 referrals European Commission final decision, 27/06/2024, 29/08/2024, 06/09/2024

Submitted by Anonymous (not verified) on 6 September 2024 - 13:40

Referral: Lorazepam Macure 4 mg/ml, solution for injection, lorazepam Article 13 referrals European Commission final decision, 27/06/2024, 29/08/2024, 06/09/2024

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness